Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488225241> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- W2488225241 endingPage "77" @default.
- W2488225241 startingPage "74" @default.
- W2488225241 abstract "The rosiglitazone decision process at FDA and EMA. What should we learn? In September 2010 the EMA decided to suspend the market authorisation of rosiglitazone while the FDA decided to restrict its use. These actions were taken because rosiglitazone had been associated with an increased risk of ischemic heart disease. Remarkably, in 2007, when the evidence against the combination of rosiglitazone and insulin had increased, the EMA made a decision that encouraged the use of insulin in combination with rosiglitazone, while the FDA tried to restrict this combination therapy. Despite the publication of several studies, including a large randomized controlled study, the cardiovascular risk of rosiglitazone has still not been definitively established. To prevent new cases like rosiglitazone, more attention should be given to evaluation of study protocols of safety trials prior to their start. The rosiglitazone story further underlines the critical importance of publicly available trial data." @default.
- W2488225241 created "2016-08-23" @default.
- W2488225241 creator A5020000643 @default.
- W2488225241 creator A5038787675 @default.
- W2488225241 date "2013-06-07" @default.
- W2488225241 modified "2023-09-23" @default.
- W2488225241 title "De besluitvorming over werkzaamheid en veiligheid van rosiglitazon bij de FDA en de EMA. Wat zijn de lessen" @default.
- W2488225241 hasPublicationYear "2013" @default.
- W2488225241 type Work @default.
- W2488225241 sameAs 2488225241 @default.
- W2488225241 citedByCount "0" @default.
- W2488225241 crossrefType "journal-article" @default.
- W2488225241 hasAuthorship W2488225241A5020000643 @default.
- W2488225241 hasAuthorship W2488225241A5038787675 @default.
- W2488225241 hasConcept C126322002 @default.
- W2488225241 hasConcept C2779306644 @default.
- W2488225241 hasConcept C2780152017 @default.
- W2488225241 hasConcept C71924100 @default.
- W2488225241 hasConceptScore W2488225241C126322002 @default.
- W2488225241 hasConceptScore W2488225241C2779306644 @default.
- W2488225241 hasConceptScore W2488225241C2780152017 @default.
- W2488225241 hasConceptScore W2488225241C71924100 @default.
- W2488225241 hasIssue "23" @default.
- W2488225241 hasOpenAccess W2488225241 @default.
- W2488225241 hasVolume "148" @default.
- W2488225241 isParatext "false" @default.
- W2488225241 isRetracted "false" @default.
- W2488225241 magId "2488225241" @default.
- W2488225241 workType "article" @default.